SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-05-040276
Filing Date
2005-08-18
Accepted
2005-08-18 15:13:26
Documents
5
Period of Report
2005-08-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a05-15084_18k.htm 8-K 44419
2 EX-10.01 a05-15084_1ex10d01.htm EX-10.01 203630
3 EX-10.02 a05-15084_1ex10d02.htm EX-10.02 186312
4 EX-10.03 a05-15084_1ex10d03.htm EX-10.03 81071
5 EX-99.1 a05-15084_1ex99d1.htm EX-99.1 12595
  Complete submission text file 0001104659-05-040276.txt   529628
Mailing Address 22026 20TH AVENUE SE, SUITE 102 BOTHELL WA 98021
Business Address 22026 2OTH AVE SE STE 102 BOTHELL WA 98021 2064879500
SONUS PHARMACEUTICALS INC (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21243 | Film No.: 051035816
SIC: 2835 In Vitro & In Vivo Diagnostic Substances